Clinical Research Agreement Template for Hong Kong

When you're planning to conduct clinical research in Hong Kong, a Clinical Research Agreement serves as the legal foundation that governs the relationship between all parties involved in the study. This comprehensive contract ensures that pharmaceutical companies, research institutions, hospitals, and investigators operate within Hong Kong's strict regulatory framework while protecting the rights and safety of research participants.

When do you need this document?

You'll need a Clinical Research Agreement whenever you're establishing a formal research partnership in Hong Kong's healthcare sector. This includes situations where a pharmaceutical company sponsors clinical trials at local hospitals, when biotechnology firms collaborate with research institutions on medical device studies, or when international sponsors work with the Hospital Authority on multi-site trials. The agreement becomes essential when you're conducting Phase I through Phase IV clinical trials, observational studies involving patient data, or any research requiring ethics committee approval. You'll also need this document when collaborating with Contract Research Organizations (CROs) to manage study operations or when multiple institutions participate in collaborative research projects.

Key legal considerations

Your Clinical Research Agreement must address several critical legal aspects to ensure compliance and protect all parties. Principal investigator qualifications and responsibilities must align with Medical Registration Ordinance requirements, while data handling provisions must strictly comply with the Personal Data (Privacy) Ordinance to protect participant confidentiality. The agreement should clearly define liability allocation, indemnification terms, and insurance coverage for potential adverse events. Intellectual property clauses must specify ownership rights for research data, discoveries, and publications. Financial arrangements, including investigator fees, institutional overhead, and study-related costs, require transparent documentation. The contract must also establish clear protocols for study monitoring, regulatory reporting, and compliance with Good Clinical Practice guidelines.

Legal requirements in Hong Kong

Under Hong Kong law, your Clinical Research Agreement must ensure compliance with the Pharmacy and Poisons Ordinance, which requires appropriate certificates and licenses for pharmaceutical trials. The agreement must incorporate Human Research Ethics Guidelines, mandating ethics committee approval and proper informed consent procedures. When involving the Hospital Authority, compliance with Hospital Authority Ordinance provisions becomes mandatory. The contract must address Personal Data (Privacy) Ordinance requirements for collecting, processing, and storing participant information, including cross-border data transfer restrictions. All parties must maintain appropriate professional indemnity insurance, and the agreement should specify reporting obligations to regulatory authorities. The document must also establish procedures for adverse event reporting, study suspension or termination, and record retention in accordance with Hong Kong's regulatory timeline requirements.